Page 1 of Clinical Trials for Spanish Cooperative Group for Gastrointestinal Tumour Therapy [SPONSOR-COLLABORATORS], 16 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
Study of First-line Single-agent Panitumumab in Frail Elderly Patients With Advanced Wild Type K-RAS Colorectal Cancer
Last Updated: February 6, 2012
Condition(s): Colorectal Cancer
2
Terminated
Phase II Study to Evaluate Safety and Efficacy of Cetuximab in Combination With XELOX for 12 Weeks Followed by Maintenance Treatment With Cetuximab Plus Capecitabine as First-line Treatment in Elderly Patients With Metastatic Colorectal Cancer.
Last Updated: February 6, 2012
Condition(s): Metastatic Colorectal Cancer
3
Active, not recruiting
Efficacy and Safety Study of Combination Therapy With Docetaxel-oxaliplatin-capecitabine in Patients With Advanced Gastric Adenocarcinoma and Intermediate General Status
Last Updated: February 6, 2012
Condition(s): Gastric Cancer
4
Recruiting
Safety and Efficacy Study of mFOLFOX-6 Plus Cetuximab for 8 Cycles Followed by mFOLFOX-6 Plus Cetuximab or Single Agent Cetuximab as Maintenance Therapy in Patients With Metastatic Colorectal Cancer and WT KRAS Tumours
Last Updated: February 6, 2012
Condition(s): Metastatic Colorectal Cancer
5
Recruiting
Safety and Efficacy Study of Gemcitabine-erlotinib Versus Gemcitabine-erlotinib-capecitabine in Patients With Metastatic Pancreatic Cancer
Last Updated: February 6, 2012
Condition(s): Metastatic Pancreatic Cancer
6
Recruiting
Axitinib as Maintenance Treatment in Patients With Metastatic CRC
Last Updated: February 6, 2012
Condition(s): Colorectal Carcinoma
7
Active, not recruiting
Selecting Treatment in Colorectal Cancer:Capecitabine or 5-fluorouracil Selection to be Combined With Oxaliplatin or Irinotecan as First-line Chemotherapy in Advanced Colorectal Cancer
Last Updated: February 6, 2012
Condition(s): Colorectal Cancer
8
Active, not recruiting
Irinotecan, Capecitabine and Bevacizumab in Metastatic Colorectal Cancer Patients
Last Updated: February 6, 2012
Condition(s): Metastatic Colorectal Cancer
9
Completed
Safety and Efficacy Study of XELOX vs. Oxaliplatin+5-FU CI as First Line Treatment in Metastatic Colorectal Cancer
Last Updated: February 6, 2012
Condition(s): Colorectal Cancer
10
Active, not recruiting
Safety and Efficacy Study to Compare Capecitabine + Bevacizumab Versus Capecitabine, Concomitantly With Radiotherapy as Neoadjuvant Treatment for Patients With Localized and Resectable Rectal Cancer
Last Updated: February 6, 2012
Condition(s): Rectal Cancer
11
Recruiting
Safety and Efficacy Study of FOLFOX4+Panitumumab vs.FOLFIRI+Panitumumab in Subjects WT KRAS Colorectal Cancer and Liver-only Metastases
Last Updated: February 6, 2012
Condition(s): Colorectal Cancer
12
Recruiting
Safety and Efficacy Study of Panitumumab+Irinotecan in Patients Wild-Type (WT) KRAS Metastatic Colorectal Cancer Refractory to Irinotecan Based Chemotherapy (SPECTRA)
Last Updated: February 6, 2012
Condition(s): Metastatic Colorectal Cancer
13
Completed
Safety and Efficacy Study of Combination Therapy With Cetuximab and FOLFOX4 in Patients With Colorectal Cancer
Last Updated: February 6, 2012
Condition(s): Colorectal Cancer
14
Active, not recruiting
A Study to Evaluate the Combination of Cetuximab and Chemotherapy as Neoadjuvant Therapy Followed Concomitant Chemoradiotherapy Plus Cetuximab in Locoregional Esophageal Carcinoma
Last Updated: February 6, 2012
Condition(s): Esophageal Carcinoma
15
Completed
Panitumumab in Combination With Irinotecan Chemotherapy as 2nd-line Therapy in Subjects With mCRC
Last Updated: February 6, 2012
Condition(s): Metastatic Colorectal Cancer
16
Active, not recruiting
Study of Bevacizumab Alone or Combined With Capecitabine and Oxaliplatin as Support Therapy in Metastatic Colorectal Cancer Patients
Last Updated: March 22, 2012
Condition(s): Colorectal Cancer

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Spanish+Cooperative+Group+for+Gastrointestinal+Tumour+Therapy

Page 1 of Clinical Trials for Spanish Cooperative Group for Gastrointestinal Tumour Therapy [SPONSOR-COLLABORATORS], 16 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About